In a filing, Bio-Techne Corp revealed its Director BAUMGARTNER ROBERT V unloaded Company’s shares for reported $1.15 million on Aug 08 ’24. In the deal valued at $72.10 per share,16,000 shares were sold. As a result of this transaction, BAUMGARTNER ROBERT V now holds 43,401 shares worth roughly $2.9 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, ROBERT V. BAUMGARTNER bought 16,000 shares, generating $1,153,664 in total proceeds.
Before that, HIGGINS JOHN L sold 4,000 shares. Bio-Techne Corp shares valued at $335,377 were divested by the Director at a price of $83.84 per share. As a result of the transaction, HIGGINS JOHN L now holds 36,608 shares, worth roughly $2.45 million.
Citigroup downgraded its Bio-Techne Corp [TECH] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early February with a ‘”a Sector outperform”‘ rating. Stifel also remained covering TECH and has decreased its forecast on February 02, 2024 with a “Hold” recommendation from previously “Buy” rating. UBS started covering the stock on December 07, 2023. It rated TECH as “a Buy”.
Price Performance Review of TECH
On Monday, Bio-Techne Corp [NASDAQ:TECH] saw its stock fall -1.05% to $66.86. Over the last five days, the stock has lost -10.48%. Bio-Techne Corp shares have fallen nearly -13.35% since the year began. Nevertheless, the stocks have risen 9.79% over the past one year. While a 52-week high of $85.57 was reached on 05/15/24, a 52-week low of $60.53 was recorded on 04/18/24. SMA at 50 days reached $74.12, while 200 days put it at $73.62.
Levels Of Support And Resistance For TECH Stock
The 24-hour chart illustrates a support level at 66.07, which if violated will result in even more drops to 65.28. On the upside, there is a resistance level at 67.57. A further resistance level may holdings at 68.28. The Relative Strength Index (RSI) on the 14-day chart is 34.70, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -5.21, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.13%. Stochastics %K at 11.76% indicates the stock is a buying.
How much short interest is there in Bio-Techne Corp?
A steep rise in short interest was recorded in Bio-Techne Corp stocks on 2024-10-31, dropping by -0.35 million shares to a total of 3.17 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 3.52 million shares. There was a decline of -10.9%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 28, 2023 when William Blair began covering the stock and recommended ‘”an Outperform”‘ rating .
